O75164 (KDM4A_HUMAN) Homo sapiens (Human)
Lysine-specific demethylase 4A UniProtKBInterProSTRINGInteractive Modelling
1064 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
89 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H4(1-15)R3me2s PEPTIDE |
Heteromer P62805; | 100 | 1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL; | |||
| Crystal structure of human KDM4A complexed with co-substrate analog NOG and histone H3 peptide with… |
Heteromer P68431; | 100 | 2×ZN; 1×OGA; | |||
| Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9 |
Heteromer P68431; | 100 | 1×NI; 1×ZN; 1×CL; 1×OGA; | |||
| JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
Heteromer Q16695; | 100 | 1×NI; 1×ZN; 1×GOL; 1×2HG; | |||
| Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9 |
Heteromer P68431; | 100 | 1×NI; 1×ZN; 1×OGA; | |||
| JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (16-35) |
Heteromer Q16695; | 100 | 1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL; | |||
| JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (25-29) ARK(me3)SA |
Heteromer Q16695; | 100 | 1×OGA; 1×NI; 1×ZN; | |||
| Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9 |
Heteromer P68431; | 100 | 1×NI; 1×ZN; 1×OGA; | |||
| JMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
Heteromer Q16695; | 100 | 1×NI; 1×ZN; 1×GOL; 1×S2G; | |||
| The complex structure of JMJD2A and trimethylated H3K36 peptide |
Heteromer P84239; | 100 | 1×ZN; 1×FE2; 1×OGA; 2×OXY; | |||
| JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Histone H1.4(18-32)K26me3 peptide (15-mer) |
Heteromer P10412; | 100 | 1×NI; 1×ZN; 1×CL; 1×OGA; 3×GOL; | |||
| Histone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to N-oxalyl-D-… |
Heteromer P68431; | 100 | 1×NI; 1×ZN; 1×08P; | |||
| JMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of double tudor domain of human lysine demethylase KDM4A complexed with histone H… |
Heteromer P68431; | 100 | ||||
| JMJD2A/ KDM4A COMPLEXED WITH NI(II) AND Macrocyclic PEPTIDE Inhibitor CP2 (13-mer) | homo-4-mer | 100 | 4×NI; 4×ZN; 3×CL; 5×GOL; 3×PPI; | |||
| JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Macrocyclic PEPTIDE Inhibitor CP2_R6Kme3 (13-mer) | homo-4-mer | 100 | 4×NI; 4×ZN; 4×OGA; 5×GOL; 5×CL; | |||
| Crystal structure of JMJD2A complexed with 3,4-dihydroxybenzoic acid | homo-2-mer | 100 | 2×DHB; 2×NI; 2×ZN; 2×CL; | |||
| Crystal structure of JMJD2A complexed with bipyridyl inhibitor | monomer | 100 | 1×NI; 1×ZN; 1×KC6; 4×CL; 1×NA; | |||
| Jumonji domain-containing protein 2A with crystallization epitope mutations A91T:T93S | monomer | 99.42 | 1×NI; 3×SO4; 1×ZN; 5×EDO; | |||
| Crystal Structure of KDM4A with compound YP-02-145 | monomer | 100 | 1×ZN; 3×NI; 2×EDO; 2×CIT; 1×GOL; | |||
| Crystal structure of human JMJD2A in complex with compound 30 | monomer | 100 | 2×MN; 1×KCH; 1×ZN; 2×CL; | |||
| Crystal structure of human JMJD2A in complex with pyruvate | monomer | 100 | 1×NI; 2×PYR; 1×DMS; 9×EDO; 1×ZN; | |||
| Crystal structure of human JMJD2A in complex with compound 42 | monomer | 99.72 | 1×SO4; 1×7WH; 11×EDO; 1×ZN; 1×MN; 1×DMS; | |||
| Crystal Structure of JMJD2A Complexed with Inhibitor | monomer | 100 | 1×NI; 1×ZN; 1×HQ2; 1×GOL; | |||
| Crystal structure of human JMJD2A in complex with compound 40 | monomer | 100 | 1×SO4; 1×MN; 1×9CJ; 1×ZN; 5×EDO; | |||
| Crystal structure of human JMJD2A in complex with fumarate | monomer | 100 | 1×ZN; 1×FUM; 1×SO4; 1×MN; 1×EDO; | |||
| Crystal structure of human JMJD2A in complex with compound 43 | monomer | 100 | 1×MN; 1×ZN; 5×EDO; 1×SO4; 1×VAO; | |||
| Crystal Structure of KDM4A with Compound 14 | monomer | 100.0 | 1×NI; 1×ZN; 1×QC1; | |||
| Crystal structure of human KDM4A in complex with compound 58 | monomer | 100 | 2×ZN; 1×N5J; 12×EDO; 2×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 54j | monomer | 100.0 | 2×ZN; 1×5UJ; 1×DMS; | |||
| Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid | monomer | 100 | 1×NI; 1×ZN; 1×PD2; | |||
| Crystal structure of human JMJD2A in complex with compound 36 | monomer | 100 | 1×SO4; 1×MN; 1×ZN; 4×EDO; 1×6Z1; 1×DMS; | |||
| Crystal Structure of JMJD2A Complexed with Inhibitor | monomer | 100 | 1×NI; 1×ZN; 1×CL; 1×0WS; | |||
| Crystal structure of human JMJD2A in complex with D-threo-isocitrate | monomer | 100 | 1×NI; 1×ZN; 1×N81; 1×DMS; 3×EDO; | |||
| Crystal Structure of Human KDM4 with Small Molecule Inhibitor QC5714 | monomer | 100.0 | 1×NI; 1×ZN; 1×9FJ; | |||
| Crystal Structure of KDM4A with compound YP-03-038 | monomer | 100 | 1×ZN; 2×NI; 2×EDO; 2×CIT; | |||
| Crystal structure of human KDM4A in complex with compound 17f | monomer | 100.0 | 2×ZN; 1×FQB; 1×DMS; 1×GOL; | |||
| Crystal structure of human KDM4A in complex with compound 34g | monomer | 100.0 | 2×ZN; 1×FQN; 1×CL; 2×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 54a | monomer | 100.0 | 2×ZN; 1×5UO; 1×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 16a | monomer | 100 | 2×ZN; 1×FQ5; 3×DMS; 1×CL; | |||
| Crystal structure of human JMJD2A in complex with compound 14a | monomer | 100 | 1×EDO; 1×SO4; 1×NI; 1×ZN; 1×LEL; | |||
| Crystal structure of human KDM4A in complex with compound 17b | monomer | 100.0 | 2×ZN; 1×FNQ; 1×DMS; 1×GOL; 1×CL; | |||
| Crystal structure of the catalytic core domain of jmjd2a | monomer | 100 | 1×ZN; 1×FE2; | |||
| JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE | monomer | 100 | 1×NI; 1×ZN; 1×CL; 1×2HG; | |||
| Crystal Structure of human JMJD2A complexed with KDOOA011340 | monomer | 100 | 1×NI; 1×ZN; 1×SO4; 1×5V1; | |||
| JMJD2A in complex with Ni(II) and alpha-Ketoglutarate | monomer | 100 | 1×NI; 1×AKG; 1×ZN; | |||
| JMJD2A Complexed with Daminozide | monomer | 100 | 1×NI; 1×ZN; 1×CL; 2×DZA; | |||
| Crystal Structure of KDM4A with Compound 8 | monomer | 100.0 | 1×NI; 1×ZN; 1×QC2; | |||
| Crystal structure of human KDM4A in complex with compound 19a | monomer | 100.0 | 2×ZN; 1×FOW; 1×CL; | |||
| JMJD2A COMPLEXED WITH 8-HYDROXYQUINOLINE-4-CARBOXYLIC ACID | monomer | 100 | 1×NI; 1×ZN; 1×CL; 1×8HQ; 1×GOL; | |||
| JMJD2A in complex with Ni(II) | monomer | 100 | 1×NI; 1×ZN; | |||
| The complex structure of JMJD2A and monomethylated H3K36 peptide | monomer | 100 | 1×ZN; 1×FE2; 1×OGA; | |||
| The crystal structure of JMJD2A complexed with Ni and N-oxalylglycine | monomer | 100 | 1×NI; 1×ZN; 1×OGA; | |||
| Jumonji domain-containing protein 2A with crystallization epitope mutatios K330R:A334E | monomer | 99.42 | 1×NI; 1×ZN; | |||
| Crystal structure of human KDM4A in complex with compound 18a | monomer | 100.0 | 2×ZN; 1×FQH; 1×GOL; 1×CL; | |||
| Crystal structure of catalytic core domain of jmjd2A complexed with alpha-Ketoglutarate | monomer | 100 | 1×ZN; 1×FE2; 1×AKG; | |||
| Crystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinate | monomer | 100 | 1×NI; 1×ZN; 1×SIN; | |||
| Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36 | monomer | 100 | 1×NI; 1×ZN; 1×OGA; | |||
| Crystal structure of human KDM4A in complex with compound 34a | monomer | 100.0 | 2×ZN; 1×FO2; 2×GOL; 1×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 16m | monomer | 100.0 | 2×ZN; 1×FQE; 3×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 53a | monomer | 100.0 | 2×ZN; 1×5UL; 2×DMS; | |||
| Crystal structure of JMJD2A complexed with 5-carboxy-8-hydroxyquinoline | monomer | 100 | 1×NI; 1×ZN; 1×8XQ; | |||
| Crystal structure of human KDM4A in complex with compound 19d | monomer | 100.0 | 2×ZN; 1×FQQ; 1×DMS; 1×CL; | |||
| The Crystal Structure of JMJD2A(M1-L359) from Biortus. | monomer | 100.0 | 1×NI; 1×ZN; | |||
| Crystal structure of human KDM4A in complex with compound 15 | monomer | 100.0 | 2×ZN; 1×5TZ; 7×EDO; 2×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 34b | monomer | 100.0 | 2×ZN; 1×FO2; 1×DMS; 1×GOL; 1×CL; | |||
| Crystal structure of human JMJD2A in complex with succinate | monomer | 100 | 1×NI; 1×ZN; 1×FUM; 5×EDO; 1×SO4; | |||
| Crystal structure of human JMJD2A in complex with compound 35 | monomer | 100 | 1×SO4; 1×35M; 1×MN; 1×ZN; 2×EDO; 1×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 17e | monomer | 100.0 | 2×ZN; 1×FO8; 1×CL; | |||
| STRUCTURE OF JMJD2A COMPLEXED WITH INHIBITOR 10A | monomer | 100 | 1×NI; 1×ZN; 1×Y28; | |||
| Crystal structure of human KDM4A in complex with compound 16 | monomer | 100.0 | 2×ZN; 1×5UP; 3×EDO; 1×DMS; | |||
| Crystal structure of human KDM4A in complex with compound 37 | monomer | 100.0 | 2×ZN; 1×5UB; 4×DMS; | |||
| Crystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutarate | monomer | 100 | 1×NI; 1×ZN; 1×AKG; | |||
| Crystal structure of human KDM4A in complex with compound 52d | monomer | 100.0 | 2×ZN; 1×5U8; 4×DMS; 1×GOL; | |||
| Crystal Structure of KDM4 with the Small Molecule Inhibitor QC6352 | monomer | 100 | 1×NI; 1×ZN; 1×9DJ; | |||
| Crystal structure of human JMJD2A in complex with compound 44 | monomer | 100 | 1×MN; 1×ZN; 7×EDO; 1×S2X; 1×DMS; | |||
| Crystal structure of human JMJD2A in complex with compound KDOAM20A | monomer | 100.0 | 1×MN; 1×MMK; 1×ZN; 3×NI; | |||
| inhibitors of JumonjiC domain-containing histone demethylases | monomer | 100 | 1×5YQ; 1×FE2; 2×SO4; 1×ZN; 3×CL; | |||
| Crystal structure of human KDM4A in complex with compound 40 | monomer | 100.0 | 2×ZN; 1×5V7; 1×DMS; 1×EDO; 1×GOL; | |||
| Specificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylase | monomer | 100 | 1×NI; 1×ZN; 1×OGA; | |||
| Jumonji domain-containing protein 2A with crystallization epitope mutations Q953E:A958D | monomer | 97.39 | 5×EDO; 2×SO4; | |||
| Jumonji domain-containing protein 2A with crystallization epitope mutation R913A | monomer | 99.13 | 3×SO4; 1×GOL; | |||
| JMJD2A hybrid tudor domains | monomer | 100 | 3×SO4; | |||
| Crystal structure of double tudor domain of human lysine demethylase KDM4A | monomer | 100 | 1×SRT; | |||
| Crystal structure of double tudor domain of human lysine demethylase KDM4A | monomer | 100 | 2×SO4; | |||
| Double tudor domain structure | monomer | 100 | 1×SO4; | |||
| double tudor domain complex structure | monomer | 100.0 | ||||
| The Crystal Structure of human JMJD2A Tudor domain from Biortus | monomer | 100 | 1×SO4; | |||
| Crystal structure of KDM4A tandem TUDOR domain in complex with a tri-methyl lysine competitive inhi… | monomer | 100 | 1×92Y; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5f37.4.A | monomer | 0.87 | 2×ZN; 1×N5J; | 100.00 | ||
| 2gf7.3.A | monomer | 0.81 | 100.00 | |||
| 6u04.1.A | monomer | 0.59 | 4×ZN; | 39.35 | ||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5d6w.3.A | monomer | 0.79 | 1×SRT; | 100.00 | ||
| Isoform 2 | 2xdp.1.A | monomer | 0.63 | 67.52 | |||
| Isoform 2 | 5erc.1.A | monomer | 0.59 | 3×ZN; | 39.87 | ||
| Isoform 2 | 5zcj.1.C | monomer | 0.56 | 24.11 | |||